GN
Therapeutic Areas
Curesponse Pipeline
| Drug | Indication | Phase |
|---|---|---|
| cResponse™ assay | Solid Tumors | Commercial |
Leadership Team at Curesponse
DV
Dr. Vered Bar
Vice President Research & Development
DR
Dr. Ravid Straussman
Scientific Founder
DS
Dr. Seth Salpeter
Co-Founder & CTO
RV
Ronen Viner
VP Business Development
ED
Eran Dor
CFO
DL
Dana Laufer‑Sheinfeld
QA Manager
DS
Dr. Sandra Hanks
UK Laboratory Director
DA
Dr. Adi Zundelevich
IL Laboratory Manager